Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Marianne Hartford, MD
Man Max 99 years
Marianne Hartford, MD
Update Il y a 4 ans
Study to Assess the Effect of Ticagrelor on Coronary Blood Flow in Healthy Male Subjects
The purpose of this study is to determine if Ticagrelor increases the Adenosin induced coronary blood flow velocity.
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Marianne Hartford, MD PhD
Update Il y a 4 ans
Study to Investigate Safety and Tolerability Single Ascending Doses of AZD4017
The primary aim of this study is to investigate the safety and tolerabilty of AZD4017 when given as single oral ascending doses to healthy volunters. This will be done by comparing the eff...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Marianne Hartford, MD PhD
Update Il y a 4 ans
Study to Investigate Safety, Tolerability and Pharmacokinetics With Single and Multiple Ascending Doses of AZD1446
This study is designed to evaluate the safety, tolerability and PK of AZD1446 in Subjects when given as multiple dose administration for either 7 Days (Day 1 single dose, Day 2-6 multiple ...
Country
Sweden
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Marianne Hartford, MD PhD
Update Il y a 4 ans
Phase I Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD4017 After Repeated Ascending Oral Doses
The primary aim of this study is to investigate the safety and tolerability of AZD4017 when given as multiple oral ascending doses to healthy volunteers. This will be done by comparing the...
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Marianne Hartford, MD, PhD
Update Il y a 4 ans
Single Ascending Dose Study (SAD) iv Formulation
The purpose is to study the safety of AZD1305, how AZD1305 is tolerated and how the medication is metabolised by the body (how it is taken up into the body, distributed around the body and...
Country
Sweden
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Marianne Hartford, MD, PhD
Update Il y a 4 ans
Study of an Extended Release (ER) Tablet, Single and Repeated Dosing
The purpose is to study the safety and tolerability of increasing doses of AZD1305 and how the medication is metabolised by the body (how it is taken up, distributed, and how it disappears...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Marianne Hartford, MD
Update Il y a 4 ans
Investigate the Effect of AZD1305 on Patients With Left Ventricular Dysfunction
To explore if AZD1305 compromises left ventricular performance in patients with left ventricular dysfunction
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Marianne Hartford, MD
Update Il y a 4 ans
Study to Investigate Safety and Tolerability of a Single Dose of AZD6482
AZD6482 is a new drug substance aiming to prevent blood clots which may arise in atherosclerotic blood vessels and cause myocardial infarction or stroke. This is the first study with AZD64...
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Marianne Hartford, MD, PhD
Update Il y a 4 ans
An Interaction Study With Digoxin and AZD1305
The primary purpose of this study is to learn more about how digoxin is handled by the body, i.e. absorption, distribution, metabolism and excretion, when administered alone and in combina...
Country
Sweden
organs
None
Specialty
None
Closed trial
More information